The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
about
Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation.Functional impairment of activated protein C in breast cancer - relationship to survival outcomes.Recombinant Thrombomodulin (Solulin) Ameliorates Early Intestinal Radiation Toxicity in a Preclinical Rat Model.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Dual functionalized poly(vinylidene fluoride) membrane with acryloylmorpholine and argatroban to improve antifouling and hemocompatibility.
P2860
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
@en
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
@nl
type
label
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
@en
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
@nl
prefLabel
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
@en
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
@nl
P2093
P2860
P1433
P1476
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
@en
P2093
Akihiko Matsumine
Akihiro Sudo
Atsumasa Uchida
Hiroki Wakabayashi
Kunihiro Asanuma
Nobuyuki Akita
Takayuki Okamoto
Tatsuya Hayashi
Tomoaki Yoshikawa
Yumiko Asanuma
P2860
P2888
P304
P356
10.1007/S12282-012-0334-5
P577
2012-02-23T00:00:00Z